4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

76.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 190.00
  • 52 Week Low: 75.00
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 2,000
  • Market Cap: £49.78m
  • Beta: 0.06

4D Pharma Overview

4D Pharma is in the pharma and biotech sector and is currently trading at 76.00p per share. In the last year 4D Pharma 's share price has ranged from 75.00p to 190.00p and brokers are currently rating this stock as 'strong buy'.

Key Personnel

CEO: Duncan Joseph Peyton
Chief Scientific Officer: Alexander James Stevenson
Independent Non-Executive Director: Axel Glasmacher
Independent Non-Executive Director: Ed Baracchini
Non-Executive Chairman: David Robert Norwood
Non-Executive Dir: Thomas Engelen

Contact Details

Address: Third Floor, 9 Bond Court, Leeds , LS1 2JZ
Phone: +44 (0) 161 837 6205
Fax: +44 (0) 161 837 6201
Website: http://www.4dpharmaplc.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BJL5BR07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 76.00p
Change Today -0.25p
% Change -0.33 %
52 Week High 190.00
52 Week Low 75.00
Volume 2,000
Shares Issued 65.49m
Market Cap £49.78m
Beta 0.06

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average
11.86% below the sector average11.86% below the sector average11.86% below the sector average11.86% below the sector average11.86% below the sector average
Price Trend
89.75% below the market average89.75% below the market average89.75% below the market average89.75% below the market average89.75% below the market average
76.67% below the sector average76.67% below the sector average76.67% below the sector average76.67% below the sector average76.67% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for 21-Aug-2019

Time Volume / Share Price
10:36 2,000 @ 75.00p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page